Calamos Advisors
AONC

Calamos Advisors’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Calamos Advisors’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-625,000
Closed -$6.28M – 1241
2022
Q4 		$6.28M Hold
625,000
– – 0.03% 601
2022
Q3 		$6.14M Buy
+625,000
New +$6.14M 0.03% 620

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Calamos Advisors's AONC Position: Q1 2023 in Review

Calamos Advisors sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 625,000 shares — an estimated $6.28M sold.

Calamos Advisors first reported a position in AONC in Q3 2022 and held it in 2 quarters. The position peaked at $6.28M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Calamos Advisors reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 625,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $6.28M.
  • Calamos Advisors first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2022 and held it in 2 quarters.
  • Calamos Advisors's American Oncology Network, Inc. Class A Common Stock position peaked at $6.28M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.